NuGen Medical Devices Inc (NGMD) — Strategic Asset Allocation Index

Latest as of March 2022: 1.9%

NuGen Medical Devices Inc (NGMD) has a Strategic Asset Allocation Index of 1.9% as of March 2022. Strategic assets (PP&E of CA$14.02K plus long-term investments of CA$-) total CA$14.02K, measured against net assets of CA$756.09K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

1.9%
Strategic Assets / Net Assets

Strategic Assets

CA$14.02K
PP&E + LT Investments

PP&E

CA$14.02K
CAD

Net Assets

CA$756.09K
CAD

Annual Strategic Asset Allocation Index for NuGen Medical Devices Inc (None–None)

The table below presents the year-by-year Strategic Asset Allocation Index for NuGen Medical Devices Inc from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see NuGen Medical Devices Inc (NGMD) market capitalisation.

Year SAAI Strategic Assets (CAD) PP&E LT Investments Net Assets Change (pp)
pp = percentage points